Acer Therapeutics Inc. Common Stock (DE) is a biopharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. With a strong pipeline of drug candidates, the company aims to provide innovative solutions for unmet medical needs.
Notification